Product

Fecal microbiota transplant

Aliases

Fecal microbiota transplant (FMT)

3 clinical trials

5 indications

Indication

Carbapenem-Resistant Enterobacteriaceae Infection

Indication

Indication

Type 2 Diabetes Mellitus

Indication

Indication

Gastrointestinal Disorder

Clinical trial

Fecal Microbiota Transplantation for Decolonization of Carbapenem-resistant Enterobacteriaceae: a Double Blind Randomized Controlled Trial

Status: Not yet recruiting, Estimated PCD: 2025-08-19

Clinical trial

Safety and Efficacy of Human Microbiota Transplantation for Overweight and Obese Type 2 Diabetes Mellitus ( SETOM ): A Randomized, Double-blind, Placebo-controlled Clinical Study

Status: Recruiting, Estimated PCD: 2025-03-01

Clinical trial

Feasibility, Safety, and Potential Efficacy of Fecal Microbiota Transplantation (FMT) for Gastrointestinal Dysfunction in Children Following Hematopoietic Cell Transplant (HCT).

Status: Not yet recruiting, Estimated PCD: 2024-12-31